These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
856 related items for PubMed ID: 7994754
1. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines. Pope BL, Chourmouzis E, MacIntyre JP, Lee S, Goodman MG. Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754 [Abstract] [Full Text] [Related]
2. The immunostimulatory compound 7-allyl-8-oxoguanosine (loxoribine) induces a distinct subset of murine cytokines. Pope BL, MacIntyre JP, Kimball E, Lee S, Zhou L, Taylor GR, Goodman MG. Cell Immunol; 1995 May; 162(2):333-9. PubMed ID: 7743561 [Abstract] [Full Text] [Related]
3. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine). Pope BL, Chourmouzis E, Sigindere J, MacIntyre JP, Capetola RJ, Lau CY. Cell Immunol; 1993 Apr 01; 147(2):302-12. PubMed ID: 8453674 [Abstract] [Full Text] [Related]
4. Loxoribine (7-allyl-8-oxoguanosine) activates natural killer cells and primes cytolytic precursor cells for activation by IL-2. Pope BL, Chourmouzis E, Victorino L, MacIntyre JP, Capetola RJ, Lau CY. J Immunol; 1993 Sep 15; 151(6):3007-17. PubMed ID: 8376766 [Abstract] [Full Text] [Related]
5. Selective modulation of elements of the immune system by low molecular weight nucleosides. Goodman MG, Reitz AB, Chen R, Bobardt MD, Goodman JH, Pope BL. J Pharmacol Exp Ther; 1995 Sep 15; 274(3):1552-7. PubMed ID: 7562533 [Abstract] [Full Text] [Related]
6. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes. Holmes KV, Welsh RM, Haspel MV. J Immunol; 1986 Feb 15; 136(4):1446-53. PubMed ID: 3003198 [Abstract] [Full Text] [Related]
7. Immunomodulatory activity of a novel nucleoside, 7-thia-8-oxoguanosine: I. Activation of natural killer cells in mice. Sharma BS, Mhaskar S, Balazs L, Siaw M. Immunopharmacol Immunotoxicol; 1992 Feb 15; 14(1-2):1-19. PubMed ID: 1597650 [Abstract] [Full Text] [Related]
8. Enhancement of immunostimulatory activity by dual substitution of C8-substituted guanine ribonucleosides: correlation with increased cytokine secretion. Pope BL, Chourmouzis E, Lee S, Goodman MG. J Immunother Emphasis Tumor Immunol; 1995 Feb 15; 17(2):98-108. PubMed ID: 7647961 [Abstract] [Full Text] [Related]
9. Topology of the loxoribine binding site. Studies with inactive loxoribine analogues. Goodman MG, Goodman JH. J Immunol; 1994 Nov 01; 153(9):4081-7. PubMed ID: 7930614 [Abstract] [Full Text] [Related]
10. A new approach to vaccine adjuvants. Immunopotentiation by intracellular T-helper-like signals transmitted by loxoribine. Goodman MG. Pharm Biotechnol; 1995 Nov 01; 6():581-609. PubMed ID: 7551237 [Abstract] [Full Text] [Related]
11. In vivo enhancement of murine natural killer cell activity by 7-allyl-8-oxoguanosine (loxoribine). Pope BL, Chourmouzis E, Sigindere J, Capetola RJ, Lau CY. Int J Immunopharmacol; 1992 Nov 01; 14(8):1375-82. PubMed ID: 1464469 [Abstract] [Full Text] [Related]
12. Immunomodulatory activity of a novel nucleoside, 7-thia-8-oxoguanosine. II. Characterization of induced effector cells and the mechanism of induction. Sharma BS, Mhaskar S, Balazs L, Jin A, Smee DF. Immunopharmacol Immunotoxicol; 1992 Nov 01; 14(1-2):21-38. PubMed ID: 1375956 [Abstract] [Full Text] [Related]
13. [TH1 response in the experimental infection with Trypanosoma cruzi]. Cardoni RL, Antúnez MI, Abrami AA. Medicina (B Aires); 1999 Nov 01; 59 Suppl 2():84-90. PubMed ID: 10668248 [Abstract] [Full Text] [Related]
14. Local and systemic immune response to inactivated Candida albicans in mice. Scaringi L, Rosati E, Cornacchione P, Fettucciari K, Sabatini R, Biondi R, Mezzasoma L, Valiani M, D'Errico P, Marconi P. Nat Immun; 1995 Sep 01; 14(5-6):234-49. PubMed ID: 8933818 [Abstract] [Full Text] [Related]
15. Genetic control of the natural killer cell activity in SJL and other strains of mice. Kaminsky SG, Nakamura I, Cudkowicz G. J Immunol; 1985 Jul 01; 135(1):665-71. PubMed ID: 3923115 [Abstract] [Full Text] [Related]
16. Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma-inducing factor on the production of interferon-gamma by natural killer. Hunter CA, Timans J, Pisacane P, Menon S, Cai G, Walker W, Aste-Amezaga M, Chizzonite R, Bazan JF, Kastelein RA. Eur J Immunol; 1997 Nov 01; 27(11):2787-92. PubMed ID: 9394800 [Abstract] [Full Text] [Related]
17. Antimetastatic effect of CpG DNA mediated by type I IFN. Hafner M, Zawatzky R, Hirtreiter C, Buurman WA, Echtenacher B, Hehlgans T, Männel DN. Cancer Res; 2001 Jul 15; 61(14):5523-8. PubMed ID: 11454702 [Abstract] [Full Text] [Related]
18. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones. van de Griend RJ, Ronteltap CP, Gravekamp C, Monnikendam D, Bolhuis RL. J Immunol; 1986 Mar 01; 136(5):1700-7. PubMed ID: 3005399 [Abstract] [Full Text] [Related]
19. Selective defect of natural killer and killer cell activity against lymphomas in SJL mice: low responsiveness to interferon inducers. Kaminsky SG, Nakamura I, Cudkowicz G. J Immunol; 1983 Apr 01; 130(4):1980-4. PubMed ID: 6833756 [Abstract] [Full Text] [Related]
20. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18. Lauwerys BR, Renauld JC, Houssiau FA. Cytokine; 1999 Nov 01; 11(11):822-30. PubMed ID: 10547269 [Abstract] [Full Text] [Related] Page: [Next] [New Search]